| Particulars |
| Company Name |
Glaxosmithkline Pharmaceuticals Ltd |
| Face Value |
10 |
| BSE Code |
500660 |
| Year End |
202303 |
| Full Year |
| Equity (Rs in Cr.) |
169.41 |
| B.V. Rs |
91.40 |
| Sales Rs in Cr. |
3,216.34 |
| NP Rs in Cr. |
586.70 |
| NP Var% |
-65.00 |
| Div% |
320.00 |
| CPS Rs |
38.50 |
| EPS Rs |
34.60 |
| Traded Value(Rs in Lakhs) |
72.53 |
| 52 Week High |
2,650.00 |
| 52 Week Low |
1,228.00 |
| Price BSE |
1,889.00 |
| Price NSE |
1,888.00 |
| Market Capital(Rs in Cr.) |
32,004.19 |
| P/C Ratio |
49.00 |
| P/E Ratio |
54.50 |
| Price Vs.BV |
20.67 |
| Latest Quarter |
| Year End |
202312 |
| Sales Rs in Cr. |
804.98 |
| NP Rs in Cr. |
177.48 |
| NP Var % |
3.00 |
| Trailing Twelve Months |
| Year End |
202312 |
| Sales |
3,234.97 |
| OPM |
27.59 |
| NP |
412.71 |
| NP Var% |
46.73 |
| EPS |
37.52 |
| PE |
50.35 |
|